Macquarie Group
KRRO icon

Macquarie Group’s Korro Bio KRRO Stock Holding History

Macquarie Group’s Portfolio KRRO Stock Details KRRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-389
Closed -$35 – 2017
2024
Q1 		$35 Buy
+389
New +$21.2K ﹤0.01% 1662
2021
Q4 		– Sell
-151
Closed -$53K – 2628
2021
Q3 		$53K Hold
151
– – ﹤0.01% 2211
2021
Q2 		$75K Buy
151
+137
+979% +$66.9K ﹤0.01% 2052
2021
Q1 		$7K Buy
+14
New +$27.2K ﹤0.01% 2429

Other funds holding KRRO

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Macquarie Group's KRRO Position: Q2 2024 in Review

Macquarie Group sold out of Korro Bio (KRRO) in Q2 2024, closing a stake of 389 shares — an estimated $35 sold.

Macquarie Group first reported a position in KRRO in Q1 2021 and held it in 4 quarters. The position peaked at $75K in Q2 2021. 64 funds tracked by Wall St. Rank hold KRRO as of Q2 2024.

  • Macquarie Group reported no remaining Korro Bio position as of Q2 2024 after selling out during the quarter.
  • Macquarie Group sold 389 Korro Bio shares in Q2 2024, an estimated $35.
  • Macquarie Group first reported a position in Korro Bio in Q1 2021 and held it in 4 quarters.
  • Macquarie Group's Korro Bio position peaked at $75K in Q2 2021.
  • 64 funds tracked by Wall St. Rank held Korro Bio as of Q2 2024.

Based on Macquarie Group's 13F filing for Q2 2024, filed 9 Aug 2024.